GPT and metabolic dysfunction-associated steatotic liver disease: The ZJU index, a novel NAFLD biomarker developed in China, combines fasting plasma glucose (FPG), TG, ALT/AST ratio, and body mass index (BMI) to assess comprehensive metabolic status (19).